Oncotelic Therapeutics (OTLC) Accumulated Expenses (2019 - 2023)
Oncotelic Therapeutics (OTLC) reported Accumulated Expenses of $781,508 for Q1 2023, down 50.5% from $1.58 million a year earlier but up 0.8% from the prior quarter.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Accumulated Expenses (2019 - 2023) Analysis & Trends
At the end of FY2022, Oncotelic Therapeutics posted Accumulated Expenses of $775,100, down 33.5% from FY2021.
- Accumulated Expenses has a three-year compound annual growth rate of 43.6% (FY2019 to FY2022).
- By year, Accumulated Expenses came in at $1.16 million in FY2021 (+45.9%), $798,386 in FY2020 (+204.8%) and $261,950 in FY2019.
- Five-year quarterly Accumulated Expenses spans a low of $230,818 in Q2 2019 and a high of $1.58 million in Q1 2022.
- Year over year, Accumulated Expenses gained in six of the last eight quarters, with growth averaging 18.4%.
- The high point for year-over-year Accumulated Expenses in five years was Q2 2020 (growth of 217.5%); the low point was Q1 2023 (a decline of 50.5%).
- Per Business Quant data, the three quarters before Q1 2023 came in at $775,100 (Q4 2022), $1.07 million (Q3 2022) and $1.06 million (Q2 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 781,508.00 |
| Dec 31, 2022 | 775,100.00 |
| Sep 30, 2022 | 1.07 Mn |
| Jun 30, 2022 | 1.06 Mn |
| Mar 31, 2022 | 1.58 Mn |
| Dec 31, 2021 | 1.16 Mn |
| Sep 30, 2021 | 1.05 Mn |
| Jun 30, 2021 | 839,801.00 |
| Mar 31, 2021 | 812,247.00 |
| Dec 31, 2020 | 798,386.00 |
| Sep 30, 2020 | 707,359.00 |
| Jun 30, 2020 | 732,780.00 |
| Mar 31, 2020 | 462,518.00 |
| Dec 31, 2019 | 261,950.00 |
| Sep 30, 2019 | 264,801.00 |
| Jun 30, 2019 | 230,818.00 |
API Access
Oncotelic Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();